Dr. Hazan on Ivermectin, COVID, and MRNA Vaccines.

 

Part 1

The Untold Story of COVID-19 Research: Dr. Sabine Hazan Speaks Out

A Gastroenterologist's Journey Through Censorship, Discoveries, and the Microbiome

Introduction: In this revealing Q&A, Dr. Sabine Hazen, a renowned gastroenterologist and microbiome researcher, shares her experiences during the COVID-19 pandemic. From groundbreaking discoveries to facing unprecedented censorship, Dr. Hazen provides an insider's perspective on the challenges of conducting independent research during a global health crisis. Her journey highlights the critical role of the gut microbiome in COVID-19 severity and treatment, as well as the obstacles faced by scientists seeking to explore alternative treatments.

Q1. [0:40] Can you tell us about your background and credentials?

Dr. Hazen explains that she's a gastroenterologist who has been conducting clinical trials for pharmaceutical companies for 30 years. Her interest in the microbiome led her to establish her own lab to understand it better. She has written 57 protocols submitted on clinicaltrials.gov and has been conducting clinical trials on the microbiome and disease.

Q2. [2:16] What do you mean when you say you wrote protocols?

Dr. Hazen describes a protocol as a detailed plan for conducting research, similar to a screenplay for a movie. It outlines how patients will be treated, followed, and how the effectiveness of the treatment will be measured. She emphasizes the importance of standardizing methods for collecting and analyzing data.

Q3. [3:30] How did your research on COVID-19 begin?

Dr. Hazen explains that her lab was the first to find COVID-19 in stool samples. This discovery led her to investigate the relationship between the virus and the gut microbiome, particularly focusing on a bacteria called Bifidobacteria. She noticed differences in the microbiome of severe COVID-19 patients compared to high-risk exposed individuals.

Q4. [11:43] What challenges did you face in conducting and publishing your research?

Dr. Hazen describes facing censorship on social media platforms when trying to advertise for clinical trial participants. She also mentions the retraction of her hypothesis paper on Ivermectin's potential effectiveness against COVID-19, highlighting the difficulties in publishing research that went against the prevailing narrative.

Q5. [14:14] How did you discover the potential of Ivermectin in treating COVID-19?

Dr. Hazen explains that her interest in Ivermectin stemmed from its connection to the same bacterial family as Bifidobacteria. She hypothesized that Ivermectin might be feeding Bifidobacteria, which could help combat the inflammatory response in COVID-19 patients. She shares an anecdote of a patient who improved rapidly after taking Ivermectin.

Q6. [41:49] What did your research reveal about the impact of COVID-19 vaccines on the gut microbiome?

Dr. Hazen discusses her study on the effects of COVID-19 vaccines on Bifidobacteria levels in the gut. She found that after vaccination, Bifidobacteria levels decreased in most patients. While she notes that the majority of vaccinated individuals are fine and their microbiome recovers, she expresses concern about a subset of people experiencing prolonged negative impacts on their gut bacteria, potentially linking this to vaccine injuries.

Time Code List:

•  0:40 - Dr. Hazen's background and credentials 
• 2:16 - Explanation of research protocols 
• 3:30 - Discovery of COVID-19 in stool samples 
• 11:43 - Challenges in conducting and publishing research 
• 14:14 - Discovery of Ivermectin's potential 
• 41:49 - Impact of COVID-19 vaccines on gut microbiome

Microbiome Maverick: Dr. Sabine Hazan's COVID-19 Research Journey

Unveiling the Gut-Lung Connection and Battling Scientific Censorship

Introduction: In the midst of the COVID-19 pandemic, while the world was grappling with uncertainty, Dr. Sabine Hazan, a distinguished gastroenterologist and microbiome researcher, embarked on a scientific odyssey that would challenge conventional wisdom and face unprecedented obstacles. This article delves into Dr. Hazan's groundbreaking research, her battles against censorship, and the critical discoveries that shed light on the intricate relationship between the gut microbiome and COVID-19. Through her experiences, we gain insight into the complexities of conducting independent research during a global health crisis and the potential implications for future pandemic responses.

Article:

Dr. Sabine Hazan, with her 30-year tenure in conducting clinical trials for pharmaceutical companies, found herself at the forefront of COVID-19 research when the pandemic struck. Her expertise in gastroenterology and keen interest in the microbiome positioned her uniquely to explore unconventional avenues in understanding and treating the novel coronavirus.

The journey began with a crucial discovery: Dr. Hazan's lab was the first to detect COVID-19 in stool samples. This finding opened up a new realm of possibilities, suggesting a potential link between the gut microbiome and the severity of COVID-19 infections. As she delved deeper, Dr. Hazan's research centered on Bifidobacteria, a type of beneficial gut bacteria that plays a vital role in maintaining immune health.

Through meticulous analysis, Dr. Hazan observed striking differences in the microbiome compositions of severe COVID-19 patients compared to high-risk exposed individuals. Severe cases showed a marked depletion of Bifidobacteria, while those who remained healthy despite exposure maintained higher levels. This observation led to a series of hypotheses and studies aimed at understanding how to bolster the gut microbiome to potentially mitigate COVID-19 severity.

However, Dr. Hazan's path was far from smooth. As she attempted to conduct clinical trials on potential treatments, including the use of hydroxychloroquine and later Ivermectin, she encountered unprecedented challenges. Social media platforms censored her attempts to recruit participants for FDA-approved clinical trials, a practice that had never been an issue in her previous decades of research. This censorship highlighted the growing tension between scientific inquiry and public health messaging during the pandemic.

The controversy surrounding Ivermectin became a focal point of Dr. Hazan's research and the challenges she faced. Her interest in Ivermectin stemmed from its connection to the same bacterial family as Bifidobacteria. She hypothesized that Ivermectin might indirectly support the growth of Bifidobacteria, potentially explaining its observed benefits in some COVID-19 patients. However, when she attempted to publish a hypothesis paper on this potential mechanism, it was retracted – an action that Dr. Hazan argues stifles scientific discourse and progress.

Despite these setbacks, Dr. Hazan persevered, conducting studies and gathering data on the relationship between the gut microbiome, COVID-19, and various treatment approaches. Her work emphasized the importance of considering the gut-lung axis in understanding COVID-19 pathology. She explained how inflammation in the gut could impact lung function and vice versa, suggesting that treatments targeting the gut microbiome could potentially alleviate respiratory symptoms.

As the pandemic progressed and vaccines became available, Dr. Hazan's research expanded to include their impact on the gut microbiome. In a study tracking participants before and after vaccination, she observed a consistent decrease in Bifidobacteria levels following vaccination. While she noted that the majority of vaccinated individuals appeared to recover their microbiome balance over time, she expressed concern about a subset of people experiencing prolonged negative impacts on their gut bacteria, potentially correlating with reported vaccine injuries.

Throughout her research journey, Dr. Hazan emphasized the importance of open scientific inquiry and the dangers of censoring hypotheses or preliminary findings. She argued that the scientific process relies on the ability to propose ideas, test them rigorously, and engage in open debate and discussion. The challenges she faced in publishing and disseminating her research highlighted broader issues within the scientific community during the pandemic, where certain narratives were prioritized over others, potentially at the cost of valuable insights.

Dr. Hazan's work underscores the complex interplay between the gut microbiome and overall health, particularly in the context of infectious diseases like COVID-19. Her findings suggest that maintaining a healthy gut microbiome, particularly with adequate levels of Bifidobacteria, could play a crucial role in resilience against severe COVID-19 outcomes. This perspective opens up new avenues for preventive strategies and potential treatments that focus on gut health as a means of bolstering overall immunity.

In conclusion, Dr. Sabine Hazan's research journey through the COVID-19 pandemic exemplifies both the potential for groundbreaking discoveries and the challenges faced by scientists pursuing unconventional hypotheses during a global health crisis. Her work not only contributes valuable insights into the role of the gut microbiome in COVID-19 but also raises important questions about scientific freedom, the peer review process, and the balance between cautious public health messaging and open scientific inquiry. As we continue to navigate the aftermath of the pandemic and prepare for future health challenges, the lessons from Dr. Hazan's experiences serve as a crucial reminder of the importance of fostering an environment that supports diverse scientific exploration and robust, unbiased research.

Part 2

Exploring Vaccine Injuries, Treatment Protocols, and the Silencing of Medical Professionals

Introduction: In this enlightening Q&A with Dr. Sabine Hazan, a renowned gastroenterologist and microbiome researcher, we delve into the controversial topics surrounding COVID-19. Dr. Hazan, with nearly three decades of experience in clinical trials, shares her insights on vaccine injuries, treatment protocols, and the concerning trend of silencing medical professionals. This article provides a candid look at the challenges faced by doctors on the front lines of the pandemic and raises important questions about medical research integrity and patient care.

Q1. [48:48] What does a vaccine injury look like?

Dr. Hazan explains that vaccine injuries can manifest in various ways, often as changes in a person's health status after receiving the vaccine. These may include:

• Digestive issues, such as diarrhea
• Hair loss
• Heart issues, including arrhythmia
• Neurological problems
• Reactivation of dormant viruses like herpes or CMV (cytomegalovirus)
• Sudden onset of conditions like Parkinson's or Alzheimer's

She emphasizes the importance of listening to patients who report changes in their health following vaccination, as these could be potential adverse events that need to be recorded and investigated.

Q2. [54:54] What are your concerns about the mRNA vaccine technology?

Dr. Hazan expresses several concerns about the mRNA vaccine technology:

• The technology is still in the research phase, despite being widely distributed
• There's a lack of long-term safety data
• The potential for the spike protein to activate or penetrate viruses in the body
• The misconception that the vaccine stays in the deltoid muscle, when in reality it can travel throughout the body
• The unknown effects of the mRNA on the gut microbiome

She stresses the need for more thorough human studies and questions the risk-benefit analysis for healthy individuals.

Q3. [59:56] How has the pandemic affected your view on medical research and public health policies?

Dr. Hazan shares that the pandemic has been an eye-opening experience, revealing:

• The importance of being vigilant as both a consumer and a doctor
• The need to conduct independent research rather than relying solely on mainstream information
• The dangers of fear-based marketing in healthcare
• The value of informed consent and allowing people to make their own health decisions
• The crucial role of front-line doctors in understanding and treating the disease

She emphasizes the importance of staying calm and rational when facing health crises.

Q4. [1:08:20] What are your thoughts on the silencing of doctors and the suppression of alternative treatment protocols?

Dr. Hazan expresses deep concern about:

• The silencing of medical professionals who propose alternative treatments
• The suppression of research on protocols like ivermectin
• The initial dismissal and later acceptance of theories like the lab leak hypothesis
• The removal of scientific abstracts and papers that challenge the mainstream narrative
• The potential conflicts of interest in research funding and publication

She believes this suppression hampers innovation and open dialogue in the medical community.

Q5. [1:09:58] Why do you think this silencing and suppression is happening?

Dr. Hazan suggests several reasons for the suppression:

• Comfort with the status quo in the medical and pharmaceutical industries
• Fear of legal repercussions for stepping outside established guidelines
• Financial interests in maintaining current treatment paradigms
• The challenge of balancing innovation with existing business models in healthcare
• The complexities of funding and publishing independent research

She advocates for a more open, collaborative approach to medical research and treatment.

Q6. [1:15:29] Where can people go to learn more about your work and research?

Dr. Hazan directs people to:

• Progenabiome, the genetic sequencing lab she created to analyze the microbiome
• U Microbiome Research Foundation, a nonprofit supporting microbiome research
• Her ongoing studies on the microbiome's role in various health conditions

She emphasizes the importance of community support in advancing medical research and the potential of microbiome studies to revolutionize our understanding of human health.

Time Code List: 

• 48:48 - Vaccine injury symptoms 
• 54:54 - mRNA vaccine technology concerns 
• 59:56 - Pandemic's impact on medical research views 
• 1:08:20 - Silencing of doctors and treatment suppression 
• 1:09:58 - Reasons for medical suppression 
• 1:15:29 - Resources for further information

Unmasking the COVID-19 Controversy: Dr. Sabine Hazan's Revelations on Vaccine Injuries, Treatment Protocols, and Scientific Censorship

A Renowned Gastroenterologist Challenges Medical Orthodoxy and Advocates for Open Scientific Discourse

Introduction: In a candid and thought-provoking interview, Dr. Sabine Hazan, a distinguished gastroenterologist with nearly three decades of experience in clinical trials, offers a critical perspective on the COVID-19 pandemic response. Drawing from her extensive background in pharmaceutical research and her front-line experience treating COVID-19 patients, Dr. Hazan provides insights into the controversial topics of vaccine injuries, alternative treatment protocols, and the alarming trend of silencing medical professionals. This article delves into Dr. Hazan's observations and concerns, shedding light on the complex interplay between medical research, public health policies, and the pharmaceutical industry during an unprecedented global health crisis.

Article:

The COVID-19 pandemic has been a watershed moment in modern medical history, not only for its global impact but also for the controversies it has sparked within the scientific community. Dr. Sabine Hazan, a respected gastroenterologist and microbiome researcher, has emerged as a vocal advocate for scientific transparency and open dialogue in the face of what she perceives as unprecedented censorship and suppression of medical information.

Vaccine Injuries: A Controversial Reality

Dr. Hazan addresses the sensitive topic of vaccine injuries, emphasizing the importance of acknowledging and investigating adverse events following vaccination. She notes that vaccine injuries can manifest in various ways, including digestive issues, hair loss, heart problems, and neurological symptoms. Of particular concern to Dr. Hazan is the potential reactivation of dormant viruses like herpes or cytomegalovirus (CMV), as well as the sudden onset of neurodegenerative conditions such as Parkinson's or Alzheimer's disease.

The gastroenterologist stresses the critical need for medical professionals to listen attentively to patients reporting health changes post-vaccination. She argues that dismissing these reports not only does a disservice to patients but also hampers the scientific process of understanding the full spectrum of vaccine effects.

mRNA Vaccine Technology: Unanswered Questions

Dr. Hazan expresses reservations about the rapid deployment of mRNA vaccine technology. She points out that despite its widespread use, the technology is still in a research phase with limited long-term safety data. Her concerns extend to the potential for the vaccine's spike protein to interact with viruses in the body in unforeseen ways.

Moreover, Dr. Hazan challenges the common assertion that the vaccine remains localized in the deltoid muscle after injection. She explains that the body's interconnected systems make it likely for the vaccine components to travel throughout the body, potentially affecting various organs and the gut microbiome. This observation underscores her call for more comprehensive human studies and a reevaluation of the risk-benefit analysis, particularly for healthy individuals.

The Pandemic's Impact on Medical Research and Public Health

The COVID-19 crisis has profoundly altered Dr. Hazan's perspective on medical research and public health policies. She advocates for increased vigilance among both medical professionals and the general public, encouraging independent research rather than unquestioning acceptance of mainstream information. Dr. Hazan criticizes the fear-based marketing that has dominated much of the pandemic response, arguing for a more balanced approach that prioritizes informed consent and individual health decisions.

Drawing from her experience treating COVID-19 patients on the front lines, Dr. Hazan emphasizes the invaluable role of clinicians in understanding and combating the disease. She contends that the insights gained from direct patient care should be given more weight in shaping public health strategies.

Silencing of Medical Professionals: A Threat to Scientific Progress

Perhaps the most alarming trend Dr. Hazan identifies is the systematic silencing of medical professionals who propose alternative treatment protocols or challenge the prevailing narrative. She cites the suppression of research on treatments like ivermectin and the initial dismissal of theories such as the lab leak hypothesis as examples of this troubling pattern.

Dr. Hazan expresses deep concern over the removal of scientific abstracts and papers that question mainstream approaches, viewing this as a direct threat to scientific progress and innovation. She suggests that this suppression may stem from a complex web of factors, including comfort with the status quo, fear of legal repercussions, financial interests, and the challenges of balancing innovation with existing business models in healthcare.

The Root Causes of Medical Suppression

In exploring the reasons behind the suppression of alternative viewpoints, Dr. Hazan points to several systemic issues within the medical and pharmaceutical industries. She suggests that the comfort of established practices, combined with the fear of stepping outside rigid guidelines, creates a risk-averse environment that stifles innovation.

Financial interests play a significant role in maintaining current treatment paradigms, according to Dr. Hazan. She highlights the difficulties faced by independent researchers in securing funding and publishing their findings, especially when their results challenge prevailing theories or threaten existing profit models.

A Call for Open Dialogue and Collaborative Research

Despite the challenges she outlines, Dr. Hazan remains optimistic about the future of medical research. She advocates for a more open, collaborative approach that values diverse perspectives and prioritizes patient outcomes over industry interests. Dr. Hazan's work with Progenabiome, a genetic sequencing lab she founded to analyze the microbiome, and the U Microbiome Research Foundation exemplifies her commitment to advancing medical knowledge through innovative research.

Dr. Hazan emphasizes the potential of microbiome studies to revolutionize our understanding of human health. She envisions a future where the global diversity of human microbiomes is celebrated and studied, leading to more personalized and effective medical treatments.

Conclusion:

Dr. Sabine Hazan's insights offer a compelling counterpoint to the mainstream narrative surrounding the COVID-19 pandemic. Her call for greater transparency, open scientific discourse, and a return to patient-centered care challenges the medical community to reevaluate its approach to crisis management and research. As the world continues to grapple with the long-term implications of the pandemic, voices like Dr. Hazan's serve as crucial reminders of the importance of intellectual diversity and scientific integrity in advancing public health.